StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.1
  1. Startseite
  2. /Verbindung

Nizax

HCID 3033637
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
76963-41-2
Standard-SMILES
CN/C(=C\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1
InChIKey
SGXXNSQHWDMGGP-IZZDOVSWSA-N
Summenformel
C12H21N5O2S2
Durchschnittliche Molmasse
331,5 g/mol

Überblick

Nizatidine is a member of the class of 1,3-thiazoles having a dimethylaminomethyl substituent at position 2 and an alkylthiomethyl moiety at position 4. It has a role as a H2-receptor antagonist, a cholinergic drug and an anti-ulcer drug. It is an organic sulfide, a carboxamidine, a C-nitro compound, a member of 1,3-thiazoles and a tertiary amino compound.

Namen und Bezeichner

Bevorzugter Name
Nizax
IUPAC
(E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
Englischer Name
Nizatidine
Summenformel
C12H21N5O2S2
Molmasse
331.46

Namen und Synonyme

NizaxZanizalZE-101MFCD00865660ZL-101(E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamineN-(2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamineNCGC00016934-01C12H21N5O2S2CAS-76963-41-2(E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine(E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
Weitere Namen anzeigen
axidNizaxiAcinongastraxnizaxidTizanon
dimethyl[(4-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amineN'-[2-[[[2-[(Dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-N-methyl-2-nitro-1,1-ethenediamineSMR000466384Acinon (TN)Axid (TN)Nizatidine (Standard)Prestwick2_000921SCHEMBL769

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,6
Polarare Oberfläche (TPSA)
140 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
9
Schwere Atome
21
Formalladung
0
Komplexität
349

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals -> Gastric and Ulcer Drugs

Pharmaceuticals -> Listed in ZINC15

LogP1.1
Solubility · 3 Einträge

10-33mg/mL

3.86e-02 g/L

>49.7 [ug/mL] (The mean of the results at pH 7.4)

Melting Point · 2 Einträge

130-132 °C

203 °C

Physical DescriptionSolid
Collision Cross Section · 3 Einträge

168.4 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

168 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

169.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
130 · 130-1320C
Siedepunkt
478.2 · 478.2±45.0 °C(Predicted)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Sicherheitsdaten

wgk
3
hs_code
29349990
RTECS-Nr.
KM6565000
risk_code
22
Toxizität
LD50 in mice, rats (mg/kg): 265, >300 i.v.; 1685, 1680 orally (Pioch)
hazard_code
Xn
safety_code
36
Speicherklasse
11 - Combustible Solids
Giftige Stoffe Daten
76963-41-2(Hazardous Substances Data)
Hazard Classifications
Acute Tox. 4 Oral

Chemie und Industrie

Pharmakologische Informationen

Protein Binding35%
Pharmacodynamics · 1 Eintrag

Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.

Mechanism of Action · 1 Eintrag

Nizatidine competes with histamine for binding at the H<sub>2</sub>-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions. The drug also decreases the gastric acid response to stimuli such as food, caffeine, insulin, betazole, or pentagastrin.

Biological Half-Life1-2 hours
Metabolism/Metabolites · 1 Eintrag

Hepatic. Less than 7% of an oral dose is metabolized as N2-monodes-methylnizatidine, an H2-receptor antagonist, which is the principal metabolite excreted in the urine. Other likely metabolites are the N2-oxide (less than 5% of the dose) and the S-oxide (less than 6% of the dose).

Absorption, Distribution and Excretion · 3 Einträge

Rapid (bioavailability of nizatidine exceeds 70%)

0.8 to 1.5 L/kg

40-60 L/h

Cellular LocationsCytoplasm
Metabolite PathwaysNizatidine Action Pathway
Anwendungen

Zugehörige Reaktionen

5
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 1108848
HRID 1108848als Eduktuspto-grants-2000_05
Reaktionsgleichung von HRID 1108849
HRID 1108849als Produktuspto-grants-2000_05
Reaktionsgleichung von HRID 1108850
HRID 1108850als Produktuspto-grants-2000_05
Reaktionsgleichung von HRID 1108851
HRID 1108851als Produktuspto-grants-2000_05
Reaktionsgleichung von HRID 1602592
HRID 1602592als Produktuspto-grants-1999_11

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung

Datenbank-Bezeichner

CAS
76963-41-2
PubChem CID
3033637
ChEBI
CHEBI:7601
Nikkaji
J32.887A
Dichte
1.249 · 1.249±0.06 g/cm3(Predicted)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
Löslichkeit
Sparingly soluble in water, soluble in methanol.
pka
2.1 · 2.1, 6.8(at 25℃)
Aggregatzustand
Solid
Farbe
Off-White to Pale Yellow
Wasserlöslichkeit
21.4 g/L · 21.4g/L(temperature not stated)
Merck
14 · 14,6660
InChI
InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3
InChIKey
SGXXNSQHWDMGGP-UHFFFAOYSA-N
SMILES
C(NCCSCC1=CSC(CN(C)C)=N1)(NC)=C[N+]([O-])=O
CAS Datenbank
76963 · 76963-41-2(CAS DataBase Reference)
· 2 Einträge

BeschreibungNizatidine is the fifth H2-antagonist introduced to the world market as an antiulcer agent. It is reported to be effective in the treatment of both duodenal and gastric ulcers or the prevention of their recurrences. Given once-daily, nizatidine’s bioavailability is not diminished by the concurrent administration of an antacid.

VerwendenNizatidine is used for treating stomach and duodenum ulcers and other conditions accompanied by elevated acidity of the gastrointestinal tract.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

SchwefelwasserstoffDimethylamineE1,2-DiaminoethanNitromethan1,3-Dichloraceton2-Dimethylaminomethyl-4-Chloromethyl-4-hydrony thiazolineThiazolidin4-Phenylazophenylen-1,3-diaminmonohydrochloridDimethyl aminothic acetamide1-vinylpyreneDimethyl amino acetenitrileEthylacetat2-Dimethyl amino methyl-4-chloro methyl thiazole HClMethanolAnhydrous pyridineCyclohexanon1,1-Bis(methylthio)-2-nitroethylenMethyljodidKaliumcyanidAcetaldehyd-AmmoniakMethylamin, gasförmig2-Nitromethylenethiazolidine

Ergänzende Hinweise

DefinitionChEBI: A member of the class of 1,3-thiazoles having a dimethylaminomethyl substituent at position 2 and an alkylthiomethyl moiety at position 4.